Literature DB >> 20383192

The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer.

C Richard1, C Lanner, S N Naryzhny, L Sherman, H Lee, P F Lambert, I Zehbe.   

Abstract

Persistent infection with high-risk human papillomaviruses (HPVs), especially type 16 has been undeniably linked to cervical cancer. The Asian-American (AA) variant of HPV16 is more common in the Americas than the prototype in cervical cancer. The different prevalence is based on three amino acid changes within the E6 protein denoted Q14H/H78Y/L83V. To investigate the mechanism(s) behind this observation, both E6 proteins, in the presence of E7, were evaluated for their ability to extend the life span of and transform primary human foreskin keratinocytes (PHFKs). Long-term cell culture studies resulted in death at passage 9 of vector-transduced PHFKs (negative control), but survival of both E6 PHFKs to passage 65 (and beyond). Compared with E6/E7 PHFKs, AA/E7 PHFKs were significantly faster dividing, developed larger cells in monolayer cultures, showed double the epithelial thickness and expressed cytokeratin 10 when grown as organotypic raft cultures. Telomerase activation and p53 inactivation, two hallmarks of immortalization, were not significantly different between the two populations. Both were resistant to anoikis at later passages, but only AA/E7 PHFKs acquired the capacity for in vitro transformation. Proteomic analysis revealed markedly different protein patterns between E6/E7 and AA/E7, particularly with respect to key cellular metabolic enzymes. Our results provide new insights into the reasons underlying the greater prevalence of the AA variant in cervical cancer as evidenced by characteristics associated with higher oncogenic potential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20383192     DOI: 10.1038/onc.2010.93

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  34 in total

1.  HPV E6 proteins target Ubc9, the SUMO conjugating enzyme.

Authors:  Phillip R Heaton; Adeline F Deyrieux; Xue-Lin Bian; Van G Wilson
Journal:  Virus Res       Date:  2011-04-12       Impact factor: 3.303

Review 2.  Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses.

Authors:  Aloysius J Klingelhutz; Ann Roman
Journal:  Virology       Date:  2012-01-27       Impact factor: 3.616

3.  Differential in vitro immortalization capacity of eleven (probable) [corrected] high-risk human papillomavirus types.

Authors:  Denise M Schütze; Peter J F Snijders; Leontien Bosch; Duco Kramer; Chris J L M Meijer; Renske D M Steenbergen
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

4.  p53 degradation activity, expression, and subcellular localization of E6 proteins from 29 human papillomavirus genotypes.

Authors:  Thibault Mesplède; David Gagnon; Fanny Bergeron-Labrecque; Ibrahim Azar; Hélène Sénéchal; François Coutlée; Jacques Archambault
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

5.  The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.

Authors:  Hong Lou; Joseph F Boland; Edmundo Torres-Gonzalez; Anaseidy Albanez; Weiyin Zhou; Mia K Steinberg; Lena Diaw; Jason Mitchell; David Roberson; Michael Cullen; Lisa Garland; Sara Bass; Robert D Burk; Meredith Yeager; Nicolas Wentzensen; Mark Schiffman; Enrique Alvirez Freites; Eduardo Gharzouzi; Lisa Mirabello; Michael Dean
Journal:  Cancer Res       Date:  2020-07-06       Impact factor: 12.701

6.  HPV-6 Molecular Variants Association With the Development of Genital Warts in Men: The HIM Study.

Authors:  Ema Flores-Díaz; Karen A Sereday; Silvaneide Ferreira; Bradley Sirak; João Simão Sobrinho; Maria Luiza Baggio; Lenice Galan; Roberto C Silva; Eduardo Lazcano-Ponce; Anna R Giuliano; Luisa L Villa; Laura Sichero
Journal:  J Infect Dis       Date:  2017-02-15       Impact factor: 5.226

7.  An epithelial organoid model with Langerhans cells for assessing virus-host interactions.

Authors:  Robert Jackson; Statton Eade; Ingeborg Zehbe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

Review 8.  Evolution of human papillomavirus carcinogenicity.

Authors:  Koenraad Van Doorslaer; Robert D Burk
Journal:  Adv Virus Res       Date:  2010       Impact factor: 9.937

9.  The Asian-American E6 variant protein of human papillomavirus 16 alone is sufficient to promote immortalization, transformation, and migration of primary human foreskin keratinocytes.

Authors:  Sarah Niccoli; Suraj Abraham; Christina Richard; Ingeborg Zehbe
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

10.  E6/E7 Functional Differences among Two Natural Human Papillomavirus 18 Variants in Human Keratinocytes.

Authors:  Emily Montosa Nunes; Valéria Talpe-Nunes; João Simão Sobrinho; Silvaneide Ferreira; Vanesca de Souza Lino; Lara Termini; Gabriela Ávila Fernandes Silva; Enrique Boccardo; Luisa Lina Villa; Laura Sichero
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.